Texas Permanent School Fund Corp Has $728,000 Stock Position in Avanos Medical, Inc. (NYSE:AVNS)

Texas Permanent School Fund Corp decreased its position in Avanos Medical, Inc. (NYSE:AVNS) by 10.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 36,552 shares of the company’s stock after selling 4,080 shares during the period. Texas Permanent School Fund Corp owned approximately 0.08% of Avanos Medical worth $728,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. First National Bank of Omaha grew its holdings in shares of Avanos Medical by 4.5% in the 4th quarter. First National Bank of Omaha now owns 29,956 shares of the company’s stock valued at $672,000 after buying an additional 1,285 shares during the period. State Board of Administration of Florida Retirement System boosted its stake in Avanos Medical by 8.6% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 19,053 shares of the company’s stock worth $379,000 after purchasing an additional 1,516 shares during the period. Pitcairn Co. boosted its stake in Avanos Medical by 11.2% in the 1st quarter. Pitcairn Co. now owns 15,940 shares of the company’s stock worth $317,000 after purchasing an additional 1,606 shares during the period. Janney Montgomery Scott LLC boosted its stake in Avanos Medical by 19.1% in the 1st quarter. Janney Montgomery Scott LLC now owns 13,010 shares of the company’s stock worth $259,000 after purchasing an additional 2,082 shares during the period. Finally, Azzad Asset Management Inc. ADV boosted its stake in Avanos Medical by 8.5% in the 2nd quarter. Azzad Asset Management Inc. ADV now owns 28,521 shares of the company’s stock worth $568,000 after purchasing an additional 2,223 shares during the period. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Price Performance

Shares of NYSE AVNS opened at $24.14 on Friday. The firm has a market cap of $1.11 billion, a PE ratio of -18.15 and a beta of 0.91. The company has a current ratio of 2.28, a quick ratio of 1.49 and a debt-to-equity ratio of 0.13. Avanos Medical, Inc. has a 1-year low of $17.24 and a 1-year high of $25.36. The company has a fifty day moving average price of $23.32 and a 200 day moving average price of $20.85.

Avanos Medical (NYSE:AVNS) last announced its earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.05. The firm had revenue of $171.70 million during the quarter, compared to analyst estimates of $170.67 million. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The company’s revenue for the quarter was up 1.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.24 EPS. Research analysts predict that Avanos Medical, Inc. will post 1.39 earnings per share for the current fiscal year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.